Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

Bingbing Dai(The University of Texas MD Anderson Cancer Center), Jason B. Fleming(Moffitt Cancer Center)

Cell Death and Disease

July 10, 2021

10.1038/s41419-021-03970-8

Cited by 11

Related Papers

DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

|JCI Insight|2021|158

RETRACTED ARTICLE: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma

|Cell Death and Differentiation|2018|54

SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium

|PLoS ONE|2014|47

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy

|PLoS ONE|2015|30

DDR1-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS DRIVE PANCREATIC CANCER METASTASIS

|bioRxiv (Cold Spring Harbor Laboratory)|2020|10